FILTER
FILTERED INTERVIEW RESULTS
Christiana Goh Bardon
MD, MBA, MANAGING DIRECTOR, UBS ONCOLOGY IMPACT FUND MANAGED BY MPM CAPITAL & PORTFOLIO MANAGER, BURRAGE CAPITAL FUND
UBS Oncology Impact Fund is an evergreen fund specializing in investments in early stage oncology and cancer therapeutics.
Geoff Meyerson
CEO AND CO-FOUNDER, LOCUST WALK
Locust Walk is a global life science transaction firm with an integrated team-based approach across capabilities, geographies, and industry segments to deliver the right products, the right partners, and the most attractive sources of capital to get the right deals done for biopharma and medtech companies.
Jonathan Retano
FOUNDER AND CEO, PHARMAFUSION
Pharmafusion provides data warehouse and business analytics solutions for the pharmaceutical industry.
John Patrick Oroho
EXECUTIVE VICE PRESIDENT AND CHIEF STRATEGY OFFICER AT PORZIO LIFE SCIENCES
Porzio Life Sciences is dedicated to helping pharmaceutical, medical device and biotechnology organizations master the evolving regulatory environment.
Paul Hennessey
SENIOR VP SALES, CONTRACT PHARMACAL CORP. (CPC)
Contract Pharmacal Corp. manufactures and packages pharmaceuticals, over-the-counter drugs and dietary supplements.
Robert K. Coughlin
PRESIDENT & CEO, MASSBIO
MassBio’s mission is to advance Massachusetts' leadership in life sciences to grow the industry, add value to the healthcare system and improve patient lives.
Jennifer Hawks Bland
CEO, NEWYORKBIO
NewYorkBIO brings together New York’s bioscience stakeholders to advance life science research and commercialization.
Eric Falcand
VICE PRESIDENT, HEAD OF BUSINESS DEVELOPMENT AND LICENSING, SERVIER GROUP
Servier is strengthening its oncology portfolio and widneing its U.S. footprint.
James Greenwood
PRESIDENT & CEO, BIOTECHNOLOGY INNOVATION ORGANIZATION
The Biotechnology Innovation Organization (BIO) represents biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
Doug Giordano
SENIOR VP, BUSINESS DEVELOPMENT, PFIZER
A look at the latest trends in business development from a global pharma powerhouse.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Mexico Chemicals 2024
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
